Overview Financials News + Filings Key Docs Transactions Holdings Ownership
|
UBS Group AG
> ZYNE
Date | Name | Ticker | Shares | Change | Value | Change | Price |
06/30/2023 | Zynerba Pharmaceuticals, Inc. | ZYNE | 26,568 | -3,718 | 8,661,000 | -4,362,000 | $325.99 |
03/31/2023 | Zynerba Pharmaceuticals, Inc. | ZYNE | 30,286 | -11,734 | 13,023,000 | -9,248,000 | $430.00 |
12/31/2022 | Zynerba Pharmaceuticals, Inc. | ZYNE | 42,020 | 15,130 | 22,271,000 | 22,251,000 | $530.01 |
09/30/2022 | Zynerba Pharmaceuticals, Inc. | ZYNE | 26,890 | 1,988 | 20,000 | -8,000 | $0.74 |
06/30/2022 | Zynerba Pharmaceuticals, Inc. | ZYNE | 24,902 | -2,719 | 28,000 | -28,000 | $1.12 |
03/31/2022 | Zynerba Pharmaceuticals, Inc. | ZYNE | 27,621 | 16,357 | 56,000 | 24,000 | $2.03 |
12/31/2021 | Zynerba Pharmaceuticals, Inc. | ZYNE | 11,264 | 5,494 | 32,000 | 7,000 | $2.84 |
09/30/2021 | Zynerba Pharmaceuticals, Inc. | ZYNE | 5,770 | -7,052 | 25,000 | -43,000 | $4.33 |
06/30/2021 | Zynerba Pharmaceuticals, Inc. | ZYNE | 12,822 | 5,593 | 68,000 | 45,000 | $5.30 |
12/31/2020 | Zynerba Pharmaceuticals, Inc. | ZYNE | 7,229 | 1,483 | 23,000 | 3,000 | $3.18 |
09/30/2020 | Zynerba Pharmaceuticals, Inc. | ZYNE | 5,746 | 4,515 | 20,000 | 15,000 | $3.48 |
06/30/2020 | Zynerba Pharmaceuticals, Inc. | ZYNE | 1,231 | -16,849 | 5,000 | -64,000 | $4.06 |
03/31/2020 | Zynerba Pharmaceuticals, Inc. | ZYNE | 18,080 | -19,515 | 69,000 | -158,000 | $3.82 |
12/31/2019 | Zynerba Pharmaceuticals, Inc. | ZYNE | 37,595 | 2,642 | 227,000 | -37,000 | $6.04 |
09/30/2019 | Zynerba Pharmaceuticals, Inc. | ZYNE | 34,953 | -11,892 | 264,000 | -371,000 | $7.55 |
06/30/2019 | Zynerba Pharmaceuticals, Inc. | ZYNE | 46,845 | 39,121 | 635,000 | 593,000 | $13.56 |
03/31/2019 | Zynerba Pharmaceuticals, Inc. | ZYNE | 7,724 | -4,847 | 42,000 | 4,000 | $5.44 |
12/31/2018 | Zynerba Pharmaceuticals, Inc. | ZYNE | 12,571 | 6,990 | 38,000 | -8,000 | $3.02 |
09/30/2018 | Zynerba Pharmaceuticals, Inc. | ZYNE | 5,581 | 373 | 46,000 | -4,000 | $8.24 |
06/30/2018 | Zynerba Pharmaceuticals, Inc. | ZYNE | 5,208 | -2,534 | 50,000 | -47,000 | $9.60 |
12/31/2017 | Zynerba Pharmaceuticals, Inc. | ZYNE | 7,742 | -2,493 | 97,000 | 11,000 | $12.53 |
09/30/2017 | Zynerba Pharmaceuticals, Inc. | ZYNE | 10,235 | -4,119 | 86,000 | -158,000 | $8.40 |
06/30/2017 | Zynerba Pharmaceuticals, Inc. | ZYNE | 14,354 | 10,457 | 244,000 | 166,000 | $17.00 |
03/31/2017 | Zynerba Pharmaceuticals, Inc. | ZYNE | 3,897 | -932 | 78,000 | 3,000 | $20.02 |
12/31/2016 | Zynerba Pharmaceuticals, Inc. | ZYNE | 4,829 | 3,829 | 75,000 | 62,000 | $15.53 |
09/30/2016 | Zynerba Pharmaceuticals, Inc. | ZYNE | 1,000 | 1,000 | 13,000 | 13,000 | $13.00 |
03/31/2016 | Zynerba Pharmaceuticals, Inc. | ZYNE | 0 | -4,311 | 0 | -43,000 | |
12/31/2015 | Zynerba Pharmaceuticals, Inc. | ZYNE | 4,311 | 2,482 | 43,000 | 16,000 | $9.97 |
09/30/2015 | Zynerba Pharmaceuticals, Inc. | ZYNE | 1,829 | 1,829 | 27,000 | 27,000 | $14.76 |
<< Prev Next >> |
|